A University of Chicago Consortium Phase II Trial of SB-715992 in Advanced Renal Cell Cancer

BACKGROUND: Advanced renal cell cancer (RCC) continues to have a poor overall prognosis despite new FDA-approved therapies. Although taxane-based therapies are generally ineffective in RCC, research into the role of the von Hippel-Lindau protein has shown an association with microtubule dynamics. Mi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lee, Richard T., Beekman, Kathleen E., Hussain, Maha, Davis, Nancy B., Clark, Joseph I., Thomas, Sachdev P., Nichols, Katherine F., Stadler, Walter M.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704464/
https://ncbi.nlm.nih.gov/pubmed/18501078
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares